Legacy automakers are turning to the Formula E electric racing series as a laboratory for electric vehicle (EV) technology, according to CleanTechnica. The series offers a competitive platform for research and development and the potential to transfer data results to automakers’ mass production models. Formula E is the first sport in the world to be net zero carbon since inception, making it an interesting match for traditionally internal combustion engine (ICE)-focused manufacturers. Legacy automakers hope to accomplish software innovation to build better mass production EVs with enhanced performance, greater range, and higher efficiency. The series also allows manufacturers to test and develop the latest EV technology, with a particular focus on regenerative power. The Formula E series has seen significant evolution, with the introduction of the all-new GEN3 car, which is lighter, smaller, faster, and more sustainable than previous models. Manufacturers involved in Formula E include Jaguar TCS Racing, Nissan, Porsche, and Stellantis. Some manufacturers, such as BMW and Mercedes, have left the series, while others, like Ford, are redirecting their EV development efforts towards other platforms, such as Formula One.
Legacy automakers find innovation in Formula E’s EV laboratory.
Latest from Blog
Is Voltronic Power Technology Corp.’s stock reflecting financial health?
TLDR: Voltronic Power Technology’s stock has increased by 27% in the past month. The company’s ROE is at 43%, indicating efficient profitability.
Tennant Company partners with Brain Corp for innovative technology solution.
TLDR: Tennant Company has signed an exclusive agreement with Brain Corp to develop robotic cleaning machines. The partnership aims to accelerate the
Capital Investment Advisors LLC boosts stake in Align Technology, Inc.
TLDR: Capital Investment Advisors LLC increased its stake in Align Technology, Inc. by 73.1% in the 4th quarter. Institutional investors now own
Don’t overlook Lepu Medical: Strong fundamentals, underestimated by the market.
TLDR: Lepu Medical Technology (Beijing) Co., Ltd.’s fundamentals appear strong despite recent stock performance. The company’s ROE is at 10%, showing a
IGT stockholders are cashing in 20 cents in dividends now.
TLDR: – International Game Technology (NYSE:IGT) is paying out a dividend of $0.20 per share on April 9th, resulting in a dividend